Top

Published in:

01-01-2023 | Losartan | News item

Revision of precautions for drug package inserts in Japan

Published in: Reactions Weekly | Issue 1/2023

Excerpt

The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has updated package inserts for roxadustat [Evrenzo], hydrochlorothiazide products and imatinib mesilate [lGlivec]. …

Pharmaceuticals and Medical Devices Safety Information No. 397 - Important Safety Information Pharmaceuticals and Medical Devices Safety Information : No. 397, 16 Nov 2022. Available from: URL: https://www.pmda.go.jp/files/000249392.pdf

Title: Revision of precautions for drug package inserts in Japan
Publication date: 01-01-2023
Publisher: Springer International Publishing
Keywords: Losartan
Rabeprazole
Metronidazole
COVID-19 Vaccination
Clarithromycin
Thrombotic Microangiopathy
Amoxicillin
Acute Respiratory Distress-Syndrome
Valsartan
Hydrochlorothiazide
Candesartan
Imatinib
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-31415-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Revision of precautions for drug package inserts in Japan

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Adalimumab/infliximab/roflumilast

Tetryzoline

Clomipramine/paroxetine/venlafaxine

Sulfasalazine

Cytarabine/daunorubicin

Gemcitabine/paclitaxel